News

Researchers headed by a team at the California Institute of Technology developed an ultrasound-guided 3D printing technique ...
The FDA issued an RTF for sBLA of nogapendekin alfa plus BCG for BCG-unresponsive NMIBC papillary disease, following prior ...
Research and development expenses for the first quarter of 2025 increased to $9.1 million from $7.7 million for the prior ...
Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.
ImmunityBio's sBLA for Anktiva was unexpectedly rejected by the FDA, contradicting prior positive feedback and approval for a ...
The Refusal to File letter comes despite the FDA’s prior encouragement to submit a supplemental biologics license application ...
A new ultrasound-guided 3D printing technique could make it possible to fabricate medical implants in vivo and deliver tailored therapies to tissues ...
If no contracts are penned and no loanees are kept on, this is what Leeds United would be left with as their core squad ...
CG Oncology Inc.’s latest research effort to treat bladder cancer is impressing investors.The Irvine-based biopharmaceutical ...
Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research ...
The RTF letter was unexpected, especially considering the positive feedback and unanimous encouragement ImmunityBio received ...
Sindrom cri du chat adalah salah satu sindrom genetik langka yang bisa terjadi pada bayi. Ini bisa ditandai dengan suara ...